LTRN Lantern Pharma Inc
Company Analysis
Latest News
🟢 Lantern Pharma is trading 11% up with no confirmed catalyst
Lantern Pharma is trading 10.63% higher at $1.04 on October 6, 2026; no confirmed company-specific catalyst was found. - The latest release listed on the...
🟢 Lantern Pharma is trading 11% up today with no confirmed catalyst identified
Lantern Pharma is trading 10.96% higher at $0.95 on October 5, 2026, following a sharp recent decline; no confirmed company-specific catalyst for the rebound...
🟢 Lantern Pharma is trading 7.2% up today with no confirmed catalyst identified
Lantern Pharma is trading 7.21% up at $0.92 on October 5 after a steep recent decline; no confirmed catalyst for the rebound was found. - A September 30...
🔴 Lantern Pharma is trading 10.3% down today amid recent registered direct offering; link remains unconfirmed
Lantern Pharma is trading 10.3% lower at $0.90; the offering is relevant context, not a confirmed cause. - Closed September 30, 2026, the offering raised...
🔴 Lantern Pharma is trading 5.9% down today amid recent registered direct offering
Lantern Pharma is trading 5.9% down at $0.94 amid a recent offering; reporting has not confirmed it caused the October 2 move. - The company closed a...
Lantern Pharma Raises $4 Million Selling Stock Near Its Lows — Is This Survival Financing or a Springboard?
Shares of Lantern Pharma jumped 10% to $1.10 in pre-market trading on October 2, the day after the clinical-stage cancer biotech confirmed it closed a...
🟢 Lantern Pharma is trading 10% up in pre-market after raising $4 million in registered direct offering
Lantern Pharma is trading 10% up at $1.10 in pre-market on October 2, 2026, following the close of its registered direct offering. - Announced October 1, the...
Lantern Pharma Receives Nasdaq Non-Compliance Notice for Market Value Requirement
Lantern Pharma Inc. (LTRN) received a notice from The Nasdaq Stock Market on September 25, 2026, indicating that the company is not in compliance with the...
Lantern Pharma Closes $4.0 Million Registered Direct Offering and Private Placement
Lantern Pharma Inc. has closed a registered direct offering and a concurrent private placement with an institutional investor, raising gross proceeds of...
🔴 Lantern Pharma is trading 11% down today after announcing a registered direct offering
Lantern Pharma is trading at $0.97, down 10.56%, following its September 29 announcement of a registered direct offering. - The deal covers 3,669,725 shares...
🔴 Lantern Pharma is trading 5.53% down
Lantern Pharma is trading 5.53% down now at $1.02, with no clearly confirmed catalyst identified for the September 30 decline. - The September 29 close was...
🟢 Lantern Pharma is trading 7.8% up in pre-market amid announced offering targeting about $4 million
Lantern Pharma is trading 7.77% up at $1.17 in pre-market on September 30; the offering is the clearest company-specific context, but no direct link was...
🔴 Lantern Pharma is trading 6.9% down in after-hours trading after announcing registered direct offering
Lantern Pharma is trading 6.9% down in after-hours trading at $1.01 after announcing a registered direct offering expected to raise approximately $4 million...
🔴 Lantern Pharma is trading 6.4% down today after announcing a roughly $4 million direct offering
Lantern Pharma is trading at $1.02 (-6.42%) after announcing a registered direct offering expected to raise about $4 million before expenses. - The offering...
🔴 Lantern Pharma is trading 12.31% down in pre-market after announcing a $4 million registered direct offering
Lantern Pharma is trading at $0.96, down 12.31%, after announcing a registered direct offering. - On September 29, 2026, it announced 3,669,725 shares or...
🟢 Lantern Pharma is trading 8.26% up in after-hours trading — no clear company-specific catalyst
Lantern Pharma is trading at $1.18, up 8.26% after hours versus its September 28 regular-session close of $1.09, with no clear company-specific catalyst...
🔴 Lantern Pharma is trading 5.7% down with no confirmed company-specific catalyst
Lantern Pharma is trading 5.7% down at $1.15 on September 28, 2026, with no confirmed company-specific catalyst explaining the decline. - The September 22...
🟢 Lantern Pharma is trading 6.6% up in pre-market; catalyst unclear
Lantern Pharma is trading at $1.30, up 6.56%, with no confirmed catalyst for the September 28 pre-market rise. - No verified Lantern Pharma announcement...
🟢 Lantern Pharma is trading 5.79% up today amid broader market strength
Lantern Pharma is trading 5.79% up at $1.28, primarily in line with broader risk-on market sentiment. - The move follows a September 24 close of $1.21, after...
🟢 Lantern Pharma is trading 7.81% up in after-hours trading as no company-specific catalyst was verified
Lantern Pharma is trading 7.81% higher at $1.30 after hours, with no verified company-specific announcement explaining the rebound. - Shares closed September...